glp 1 agonist and dpp 4 inhibitor GLP-1 GIP therapies #diabetes #diabetesmanagement #type2diabetes #obesity #glp1 #dpp4inhibitor #weightloss #ozempic #mounjaro Target Trial of Glucagon-Like Peptide-1

Scientists barely understand the brain, and they barely understand GLP-1 drugs, so explaining GLP-1 drug function in the brain is a bit like translating a conversation conducted in two different languages youre only semi-fluent in

In a high-fat diet model of metabolic inflammation, garlic-derived EVs carrying miR-396e were found to drive macrophages from a pro-inflammatory M1 state toward an anti-inflammatory M2 phenotype, dampening adipose tissue inflammation associated with cardiovascular risk [261]

A randomized, Controlled trial of liraglutide for adolescents with obesity

Modern research into Long COVID is increasingly pointing to the gut as a primary driver of systemic symptoms

STEP 2 confirmed efficacy in diabetic populations (9.6% weight reduction)